Sustained response to lenvatinib and pembrolizumab in two patients with KRAS-mutated endometrial mesonephric-like adenocarcinoma
Sherry Shen,
Maria M. Rubinstein,
Kay J. Park,
Jason A. Konner,
Vicky Makker
Affiliations
Sherry Shen
Corresponding author at: 1275 York Avenue Box 8, New York, NY 10065, United States.; Memorial Sloan Kettering Cancer Center, New York, NY, United States
Maria M. Rubinstein
Memorial Sloan Kettering Cancer Center, New York, NY, United States
Kay J. Park
Memorial Sloan Kettering Cancer Center, New York, NY, United States
Jason A. Konner
Memorial Sloan Kettering Cancer Center, New York, NY, United States
Vicky Makker
Memorial Sloan Kettering Cancer Center, New York, NY, United States
